Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion description "[The mammalian target of rapamycin, which is a sensor of the mitochondrial transmembrane potential, has been successfully targeted for treatment of SLE with rapamycin or sirolimus in both patients and animal models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion evidence source_evidence_literature NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion SIO_000772 20014960 NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion wasDerivedFrom befree-20150227 NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion wasGeneratedBy ECO_0000203 NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- befree-20150227 importedOn "2015-02-27" NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.